Pharmaceuticals Search Engine [selected websites]

Monday, June 6, 2011

New GE Technology Targets Obesity-related Disease

GE Healthcare25 May 2011 - Visceral “Belly” Fat Application on GE Body Composition Systems Aids in Obesity Assessment and Monitoring - GE Healthcare announced 510k clearance of CoreScan – a widely-accessible application dedicated to quickly and accurately quantifying visceral adipose tissue (VAT), or visceral “belly” fat, during body composition analysis. Hosted on GE Lunar’s iDXA body composition system, CoreScan provides patients and physicians an advanced tool to quantify VAT in order to help assess, manage, and treat obesity-related disease.

“CoreScan offers instant, precise and reproducible fat-quantifying results that go beyond the bathroom scale,” said Laura Stoltenberg, general manager of GE Healthcare’s Lunar business. “As part of an iDXA body composition exam, CoreScan can help patients and physicians tailor individualized health and wellness plans while addressing the growing global danger of obesity-related disease.”... GE Healthcare's Press Release -